Vizsgálati helyszín
Instytut Zdrowia Dr Boczarska-Jedynak Sp. z o.o. S.K.
Oswiecim, 32-600, LengyelországEU-13 felzárkózó országMég nincs intézményhez kötve
- 16futó vizsgálat
- 20lezárt vizsgálat
Az itteni vizsgálatok
Miről szól a helyszín 36 vizsgálata, a regiszteri adatlapjaik szerint.
- Fázis
- 3. fázis20 vizsgálat
- 2. fázis12 vizsgálat
- 4. fázis2 vizsgálat
- 1/2. fázis1 vizsgálat
- 2/3. fázis1 vizsgálat
- Állapot
- Lezárult20 vizsgálat
- Fut, nem toboroz9 vizsgálat
- Toboroz6 vizsgálat
- Még nem toboroz1 vizsgálat
- Fő szponzor
- H. Lundbeck A/S5 vizsgálat
- Ipsen5 vizsgálat
- Hoffmann-La Roche4 vizsgálat
- Pfizer3 vizsgálat
- AbbVie2 vizsgálat
- és még 14
Futó vizsgálatok
Toboroz
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
NCT07174310· 3. fázis· Hoffmann-La Roche· Forrás
Fut, nem toboroz
A Study to Assess Bioequivalence of Two Subcutaneous (SC) Formulations of Ocrelizumab in Participants With Multiple Sclerosis (MS)
NCT07074886· 2. fázis· Hoffmann-La Roche· Forrás
Toboroz
Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368, a FAAH/MAGL Inhibitor, in Participants with Multiple Sclerosis Spasticity
2024-517745-14-00· 2. fázis· Celgene Corp.· Forrás
Fut, nem toboroz
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine
NCT07018713· 3. fázis· Merz Therapeutics GmbH· Forrás
Fut, nem toboroz
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine
NCT07018700· 3. fázis· Merz Therapeutics GmbH· Forrás
Toboroz
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
NCT06976203· 3. fázis· Bristol-Myers Squibb· Forrás
Toboroz
A Study of IPN10200 for the Treatment of Cervical Dystonia in Adults
NCT06937931· 2. fázis· Ipsen· Forrás
Toboroz
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
NCT06976268· 2/3. fázis· Biohaven Therapeutics Ltd.· Forrás
Toboroz
A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine
NCT06641466· 3. fázis· Pfizer· Forrás
Fut, nem toboroz
A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults
NCT06625060· 2. fázis· Ipsen· Forrás
Toboroz
Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients with Progressive Multiple Sclerosis
NCT05054140· 2. fázis· Immunic AG· Forrás
Toboroz
A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
NCT05164172· 3. fázis· H. Lundbeck A/S· Forrás
Toboroz
A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine
NCT04965675· 3. fázis· H. Lundbeck A/S· Forrás
Toboroz
A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Upper Limb Spasticity.
NCT04752774· 1/2. fázis· Ipsen· Forrás
Fut, nem toboroz
Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS)
NCT04586023· 3. fázis· Hoffmann-La Roche· Forrás
Fut, nem toboroz
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis (PPMS)
NCT04548999· 3. fázis· Hoffmann-La Roche· Forrás
Egyszerre toboroz
Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.
Lezárt vizsgálatok
Lezárult
A clinical trial to learn about the effects of VHB937 in people with Alzheimer's disease
2024-516966-12-00· 2. fázis· Novartis Pharma AG· Forrás
Lezárult
A Study to Evaluate the Safety, Tolerability, Preliminary Efficacy and Pharmacokinetics of iN1011-N17-02 in Patients with Post herpetic Neuralgia(PHN)
2024-518747-38-00· 2. fázis· iN Therapeutics Co. Ltd.· Forrás
Fut, nem toboroz
Study of Oral Atogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine
NCT06806293· 3. fázis· AbbVie· Forrás
Fut, nem toboroz
A Trial of Amlenetug (Lu AF82422) in Participants With Multiple System Atrophy (MSA)
NCT06706622· 3. fázis· H. Lundbeck A/S· Forrás
Lezárult
A Dose-finding Trial With Lu-AG09222 in Adults With Migraine Who Have Not Been Helped by Prior Preventive Treatments
NCT06323928· 2. fázis· H. Lundbeck A/S· Forrás
Lezárult
Study of Oral Atogepant Tablets to Assess Safety and Efficacy in Adult Participants With Migraine
NCT06241313· 3. fázis· AbbVie· Forrás
Lezárult
A 96-Week, Prospective, Multicenter, Randomised, Double-Blind, Placebo-Controlled, Phase 3 Study to Compare Efficacy and Safety of Masitinib Dose Titration to 4.5 mg/kg/day versus Placebo in the Treatment of Patients with Primary Progressive or Secondary Progressive Multiple Sclerosis Without Relapse
2024-516672-16-00· 3. fázis· Ab Science· Forrás
Fut, nem toboroz
A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Chronic Migraine in Adults
NCT06047444· 3. fázis· Ipsen· Forrás
Fut, nem toboroz
A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Episodic Migraine in Adults
NCT06047457· 3. fázis· Ipsen· Forrás
Lezárult
A Study to Learn About the Safety of BIIB091 and Its Effect on Brain Inflammation When Taken Alone or With Diroximel Fumarate (DRF) in Adults With Relapsing Forms of Multiple Sclerosis (MS)
NCT05798520· 2. fázis· Biogen· Forrás
Lezárult
An efficacy and safety study of HRO350 in patients with mild-to-moderate psoriasis (the ‘HeROPA’ study)
2022-501850-12-00· 2. fázis· Arctic Bioscience AS· Forrás
Lezárult
Efficacy and Tolerability of Rimegepant for the Prevention of Migraine in Adults With History of Inadequate Response to Oral Preventive Medications
NCT05518123· 4. fázis· Pfizer· Forrás
Lezárult
Efficacy and Tolerability of Rimegepant for the Acute Treatment of Migraine in Adults Unsuitable for Triptan Use
NCT05509400· 4. fázis· Pfizer· Forrás
Lezárult
GV1001 Subcutaneous(SC) for the Treatment of Mild to Moderate Alzheimer's Disease (AD)
NCT05189210· 2. fázis· GemVax & Kael· Forrás
Lezárult
A Study to Learn About the Safety of BIIB122 Tablets and Whether They Can Slow the Worsening of Early-Stage Parkinson's Disease in Adults Between the Ages of 30 and 80
NCT05348785· 2. fázis· Biogen· Forrás
Lezárult
Study to Assess the Efficacy, Safety, and Tolerability of Valbenazine for the Treatment of Dyskinesia Due to Cerebral Palsy
NCT05206513· 3. fázis· Neurocrine Biosciences· Forrás
Lezárult
Eptinezumab as Preventive Treatment of Migraine in Adults With Migraine
NCT04921384· 3. fázis· H. Lundbeck A/S· Forrás
Lezárult
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE)
NCT04777396· 3. fázis· Novo Nordisk A/S· Forrás
Lezárult
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus)
NCT04777409· 3. fázis· Novo Nordisk A/S· Forrás
Lezárult
Assessment of the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
NCT04408755· 3. fázis· Otsuka Pharmaceutical Development & Commercialization Inc.· Forrás
Hibát jelzek